No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 8,528 | 9,965 | 10,677 | 9,395 | 24,107 | 27,916 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 619 | 837 | 555 | 621 | 613 | 791 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
North Copper (Shanxi) Co., Ltd., headquartered in Yuncheng, China, specializes in manufacturing and distributing a diverse portfolio of inorganic chemical products. The company's offerings include yuanming powder, an essential component across various sectors such as detergents, textile printing and dyeing, glass manufacturing, papermaking, leather processing, pharmaceuticals, and the production of bath salts and different dyes. Additionally, North Copper produces barium sulfate, which finds extensive application in various coating types (including water-based, oily, and powder), inks, papermaking, engineering plastics, electrical and insulating plastics, and rubber manufacturing. Another key product is alkali sulfide, utilized in processes like vulcanizing black dyes, leather tanning, metallurgy, medicine, papermaking, textile treatment, metallic nickel production, and as an additive for carbendazim and rubber. Furthermore, the company supplies sulfonated products integral to liquid detergents such as dish soap, shampoos, foam baths, and hand sanitizers, alongside sodium sulfate. Beyond its domestic operations within China, North Copper extends its market reach internationally, exporting its chemical goods to approximately 30 countries. The enterprise was founded in 1996 and was formerly known as Nafine Chemical Industry Group Co.,Ltd.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

North Copper (Shanxi) Co., Ltd. (000737.SZ)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
North Copper (Shanxi) Co., Ltd., headquartered in Yuncheng, China, specializes in manufacturing and distributing a diverse portfolio of inorganic chemical products. The company's offerings include yuanming powder, an essential component across various sectors such as detergents, textile printing and dyeing, glass manufacturing, papermaking, leather processing, pharmaceuticals, and the production of bath salts and different dyes. Additionally, North Copper produces barium sulfate, which finds extensive application in various coating types (including water-based, oily, and powder), inks, papermaking, engineering plastics, electrical and insulating plastics, and rubber manufacturing. Another key product is alkali sulfide, utilized in processes like vulcanizing black dyes, leather tanning, metallurgy, medicine, papermaking, textile treatment, metallic nickel production, and as an additive for carbendazim and rubber. Furthermore, the company supplies sulfonated products integral to liquid detergents such as dish soap, shampoos, foam baths, and hand sanitizers, alongside sodium sulfate. Beyond its domestic operations within China, North Copper extends its market reach internationally, exporting its chemical goods to approximately 30 countries. The enterprise was founded in 1996 and was formerly known as Nafine Chemical Industry Group Co.,Ltd.
